Head to Head Review: Entellus Medical (ENTL) and iRadimed Corporation (IRMD)
Entellus Medical (NASDAQ: ENTL) and iRadimed Corporation (NASDAQ:IRMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitabiliy, institutional ownership and valuation.
Earnings and Valuation
This table compares Entellus Medical and iRadimed Corporation’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Entellus Medical||$80.80 million||4.64||-$26.99 million||($1.66)||-10.30|
|iRadimed Corporation||$24.35 million||4.28||$4.51 million||$0.24||40.63|
iRadimed Corporation has higher revenue, but lower earnings than Entellus Medical. Entellus Medical is trading at a lower price-to-earnings ratio than iRadimed Corporation, indicating that it is currently the more affordable of the two stocks.
This is a breakdown of current ratings and target prices for Entellus Medical and iRadimed Corporation, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Entellus Medical presently has a consensus target price of $22.00, indicating a potential upside of 28.65%. iRadimed Corporation has a consensus target price of $12.00, indicating a potential upside of 23.08%. Given Entellus Medical’s higher possible upside, research analysts clearly believe Entellus Medical is more favorable than iRadimed Corporation.
Volatility & Risk
Entellus Medical has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Comparatively, iRadimed Corporation has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500.
This table compares Entellus Medical and iRadimed Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
76.8% of Entellus Medical shares are held by institutional investors. Comparatively, 15.9% of iRadimed Corporation shares are held by institutional investors. 9.1% of Entellus Medical shares are held by insiders. Comparatively, 60.1% of iRadimed Corporation shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
iRadimed Corporation beats Entellus Medical on 8 of the 13 factors compared between the two stocks.
About Entellus Medical
Entellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company’s XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.
About iRadimed Corporation
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
Receive News & Stock Ratings for Entellus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entellus Medical Inc. and related stocks with our FREE daily email newsletter.